Johnson & Johnson — JNJ
| Close Price | Market Cap | P/E Ratio | Forward P/E Ratio | Implied Growth* | Implied Forward Growth* | Dividend | P/B Ratio |
|---|
| $248.43 | $598.69B | 22.5 | 19.8 | 12.4% | 11.0% | $5.20
2.1% | 7.3 |
Revenue & Net Income
|
Date |
Revenue |
Net_Income |
EPS |
Last_Updated |
Revenue_Change |
Net_Income_Change |
EPS_Change |
| 0 |
2021-12-31 |
$78,740M |
$20,878M |
$7.93 |
2026-02-13 08:39:13 |
N/A |
N/A |
N/A |
| 1 |
2022-12-31 |
$79,990M |
$17,941M |
$6.86 |
2026-02-27 21:59:35 |
1.6% |
-14.1% |
-13.5% |
| 2 |
2023-12-31 |
$85,159M |
$35,153M |
$13.88 |
2026-02-27 21:59:35 |
6.5% |
95.9% |
102.3% |
| 3 |
2024-12-31 |
$88,821M |
$14,066M |
$5.84 |
2026-02-27 21:59:35 |
4.3% |
-60.0% |
-57.9% |
| 4 |
2025-12-31 |
$94,193M |
$26,804M |
$11.13 |
2026-02-27 21:59:35 |
6.0% |
90.6% |
90.6% |
| 5 |
TTM 2025-12-31 |
$94,193M |
$26,804M |
$11.03 |
2026-01-26 08:25:38 |
0.0% |
0.0% |
-0.9% |
EPS
Forecasts
Y/Y % Change
YoY Growth Rates
JNJ Year-over-Year Growth
| |
2021 |
2022 |
2023 |
2024 |
2025 |
2026 |
2027 |
Average |
| Revenue Growth (%) |
|
1.6% |
6.5% |
4.3% |
6.0% |
6.5% |
4.5% |
4.9% |
| Revenue Analysts (#) |
0 |
0 |
0 |
0 |
0 |
7 |
7 |
|
| EPS Growth (%) |
|
-14.1% |
95.9% |
-60.0% |
90.6% |
3.8% |
7.5% |
20.6% |
| EPS Analysts (#) |
0 |
0 |
0 |
0 |
0 |
8 |
8 |
|
Expenses
| Year |
Revenue ($) |
Cost of Revenue ($) |
R&D ($) |
G&A ($) |
SG&A ($) |
Facilities / D&A ($) |
Personnel ($) |
| 2022 |
$80.0B |
$17.6B |
$14.1B |
$20.2B |
$20.2B |
$7.0B |
$-1.2B |
| 2023 |
$85.2B |
$19.1B |
$15.1B |
$21.5B |
$21.5B |
$7.5B |
$-1.4B |
| 2024 |
$88.8B |
$20.1B |
$17.2B |
$22.9B |
$22.9B |
$7.3B |
$-900.0M |
| 2025 |
$94.2B |
$22.8B |
$14.7B |
$0.0 |
$23.7B |
$7.5B |
$0.0 |
| TTM |
$94.2B |
$22.8B |
$14.7B |
$16.9B |
$23.7B |
$7.5B |
$-300.0M |
| Year |
Revenue Change (%) |
Cost of Revenue Change (%) |
R&D Change (%) |
G&A Change (%) |
SG&A Change (%) |
Facilities / D&A Change (%) |
Personnel Change (%) |
| 2023 |
6.46 |
8.18 |
6.72 |
6.25 |
6.25 |
7.40 |
16.67 |
| 2024 |
4.30 |
5.59 |
14.23 |
6.31 |
6.31 |
-1.96 |
-35.71 |
| 2025 |
6.05 |
13.02 |
-14.90 |
-100.00 |
3.53 |
2.23 |
-100.00 |
| TTM |
0.00 |
0.00 |
0.00 |
inf |
0.00 |
0.00 |
-inf |
No unmapped expenses.
Balance Sheet
| |
Metric |
Value |
| 0 |
Total Assets |
$192,816M |
| 1 |
Cash |
$18,231M |
| 2 |
Total Liabilities |
$113,539M |
| 3 |
Total Debt |
$45,795M |
| 4 |
Total Equity |
$79,277M |
| 5 |
Debt to Equity Ratio |
0.58 |
EPS & Dividend
Valuation
| Share Price |
Treasury Yield |
Estimates |
Fair Value (P/E) |
Fair Value (P/S) |
Current P/S |
Current P/E |
| $248.43 |
4.0% |
FINVIZ Growth: 8% |
Nicks: 7
Finviz: 15 |
Nick's: 0.000 |
6.4 |
22.5 |
| Basis |
Year |
Nicks Valuation |
Nicks vs Share Price |
Finviz Valuation |
Finviz vs Share Price |
| $11.03 EPS |
TTM |
$73.62 |
-70.4% |
$168.33 |
-32.2% |
| $11.54 EPS |
2026 |
$77.03 |
-69.0% |
$176.12 |
-29.1% |
| $12.40 EPS |
2027 |
$82.77 |
-66.7% |
$189.24 |
-23.8% |
Implied Growth
|
Average |
Median |
Std Dev |
Current |
Percentile |
|
TTM |
Forward |
TTM |
Forward |
TTM |
Forward |
TTM |
Forward |
TTM |
Forward |
| Timeframe |
|
|
|
|
|
|
|
|
|
|
| 1 Year |
10.92% |
9.82% |
10.84% |
10.00% |
0.68% |
0.82% |
12.26% |
10.88% |
93.2% |
88.1% |
| 3 Years |
10.92% |
9.82% |
10.84% |
10.00% |
0.68% |
0.82% |
12.26% |
10.88% |
93.2% |
88.1% |
| 5 Years |
10.92% |
9.82% |
10.84% |
10.00% |
0.68% |
0.82% |
12.26% |
10.88% |
93.2% |
88.1% |
| 10 Years |
10.92% |
9.82% |
10.84% |
10.00% |
0.68% |
0.82% |
12.26% |
10.88% |
93.2% |
88.1% |
← Back